Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

News Conference News TCT 2024

PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE

Todd Neale

October 29, 2024

News Conference News TCT 2024

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

Michael O'Riordan

October 28, 2024

News Conference News TCT 2024

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

L.A. McKeown

October 28, 2024

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

Presentation TCT 2022

Influential Trials in High-Risk PCI: Shaping the Future of Ischemic Heart Failure Therapy

Presenter: Jonathan Hill

September 18, 2022

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

L.A. McKeown

September 18, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Conference News TCT 2021

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

Todd Neale

November 05, 2021

News Conference News TCT 2020

FlowTriever Looks Good for Acute PE in Interim FLASH Results

Todd Neale

October 18, 2020

News Conference News TCT 2020

MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions

Shelley Wood

October 15, 2020

News Conference News TCT 2018

Transcatheter Mitral Valve Repair Provides Fast, Sustained Gains in Quality of Life

TCT Daily Staff

September 27, 2018

News Daily News TCT 2018

High Mortality but Durable Results With Valve-in-Valve TAVR

Michael O'Riordan

September 23, 2018

News Conference News TCT 2017

TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months

Yael L. Maxwell

November 01, 2017

Presentation TCT 2017

REVASC: A Randomized Trial to Assess Recovery of Left Ventricular Function After PCI of Coronary Artery Chronic Total Occlusions

Presenter: Robert-Jan van Geuns, Kambis Mashayekhi

October 31, 2017

Presentation TCT 2017

RECOVERY: A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES With a Luminal CD34+ Antibody Coating vs a Polymer-Free Metallic DES in Patients With Coronary Artery Disease

Presenter: David P. Faxon, Joseph A. Hill, Ling Tao

October 31, 2017

News Conference News TCT 2017

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

Michael O'Riordan

October 30, 2017

News Conference News TCT 2016

CMR Subanalysis of EXPLORE May Help Pinpoint Which CTO Regions Benefit From PCI

Yael L. Maxwell

November 01, 2016

Presentation TCT 2016

EXPLORE: Left Ventricular Function Recovery from a Prospective, Randomized Trial of CTO Intervention after Primary PCI in Patients with STEMI

Presenter: Joseph A. Hill, Steven P. Marso, Jose P.S. Henriques

October 31, 2016

Advertisement

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for Acute PE

EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis

EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Influential Trials in High-Risk PCI: Shaping the Future of Ischemic Heart Failure Therapy

FLASH: More Data to Support Mechanical Thrombectomy in PE

New Faces, New Formats, New Tech: What to Expect From TCT 2022

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

FlowTriever Looks Good for Acute PE in Interim FLASH Results

MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions

Transcatheter Mitral Valve Repair Provides Fast, Sustained Gains in Quality of Life

High Mortality but Durable Results With Valve-in-Valve TAVR

TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months

REVASC: A Randomized Trial to Assess Recovery of Left Ventricular Function After PCI of Coronary Artery Chronic Total Occlusions

RECOVERY: A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES With a Luminal CD34+ Antibody Coating vs a Polymer-Free Metallic DES in Patients With Coronary Artery Disease

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

CMR Subanalysis of EXPLORE May Help Pinpoint Which CTO Regions Benefit From PCI

EXPLORE: Left Ventricular Function Recovery from a Prospective, Randomized Trial of CTO Intervention after Primary PCI in Patients with STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content